Hydrochlorothiazide
Hydrochlorothiazide is a thiazide diuretic medication used to treat high blood pressure and fluid retention (edema). This generic version, in 12.5 mg capsules, is taken orally and was marketed by Alembic Pharmaceuticals. It works by increasing urine output to reduce swelling and blood pressure. Note: This product is discontinued. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Hydrochlorothiazide is a thiazide diuretic medication used to treat high blood pressure and fluid retention (edema). This generic version, in 12.5 mg capsules, is taken orally and was marketed by Alembic Pharmaceuticals. It works by increasing urine output to reduce swelling and blood pressure. Note: This product is discontinued. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Hydrochlorothiazide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Hydrochlorothiazide — ANDA 200797 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200797"
}
]
|
| identifier | ANDA200797 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"drug-safety",
"health-care",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Hydrochlorothiazide |
